Oracle stock rises in premarket on plans to cut thousands of jobs

[ad_1] Oracle Corp. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Wednesday, Dec. 31, 2025. Michael Nagle | Bloomberg | Getty Images Oracle rose in premarket trading on Wednesday as the multinational tech conglomerate looks to cut thousands of jobs to free up cash to build AI […]

CNBC Daily Open: Get ready for Trump’s Iran war update

[ad_1] U.S. President Donald Trump speaks during a Cabinet meeting in the Cabinet Room of the White House on March 26, 2026 in Washington, DC. Chip Somodevilla | Getty Images Hello, this is Holly Ellyatt writing to you from London. Welcome to another edition of CNBC’s Daily Open. Global markets will be on tenterhooks today […]

JetBlue Airways raises checked bag fees at least $4 as fuel prices soar

[ad_1] A JetBlue Airways Airbus A321 airplane departs from Los Angeles International Airport en route to New York on Oct. 17, 2025. Kevin Carter | Getty Images JetBlue Airways is raising bag fees at least $4 as jet fuel prices soar amid the Iran war. Airfare has climbed for routes around the world since the […]

Powell sees inflation outlook in check, no need to hike rates because of oil shock

[ad_1] Federal Reserve Chair Jerome Powell, in a wide-ranging talk at Harvard University, said Monday that he sees inflation expectations as grounded despite rising energy prices so the central bank doesn’t need to respond with higher interest rates. As his term leading the central bank nears an end, Powell avoided questions about the longer-term direction […]

Pricy airfare, airport chaos test travelers’ willingness to fly this year

[ad_1] Travelers wait in line at a Transportation Security Administration (TSA) checkpoint at George Bush Intercontinental Airport (IAH) in Houston, Texas, US, on Thursday, March 26, 2026. Mark Felix | Bloomberg | Getty Images TOKYO/NEW YORK — Genevieve Price considers herself a great flight hacker. The 35-year-old naturopathic doctor based in San Diego usually buys […]

AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed

[ad_1] AstraZeneca‘s stock jumped nearly 5% after Britain’s most valuable company said its experimental lung disease medicine met its target in two late-stage clinical trials. The respiratory treatment tozorakimab, reduced flare-ups of chronic obstructive pulmonary disease (COPD) in both former smokers and in the overall population versus placebo, the company said. “This marks a notable […]